Pacific Edge Limited
Clinical trials sponsored by Pacific Edge Limited, explained in plain language.
Pacific Edge is a diagnostics company developing urine-based tests for bladder cancer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Urine test may spare thousands from painful bladder scopes
Diagnosis Recruiting nowThis study looks at 1,000 adults who have microscopic blood in their urine (microhematuria), which can be a sign of bladder cancer. Currently, many need a cystoscopy—a camera inserted into the bladder—which can be uncomfortable. The study tests whether a urine test called Cxbladd…
Sponsor: Pacific Edge Limited • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Pee test may spare thousands from painful bladder scopes
Diagnosis Recruiting nowThis study is testing a new, non-invasive urine test called Cxbladder Triage-Plus to see if it can accurately detect bladder cancer in people who have microscopic blood in their urine. Currently, these patients often need a cystoscopy, an invasive procedure where a camera is inse…
Sponsor: Pacific Edge Limited • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Pee test could replace scope for bladder cancer checks
Diagnosis Recruiting nowThis study is testing a simple urine test called CxBladder to see if it can accurately detect when bladder cancer comes back. Currently, patients need a camera inserted into the bladder (cystoscopy) for monitoring, which is uncomfortable and costly. The study will collect urine s…
Sponsor: Pacific Edge Limited • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC